XML 38 R13.htm IDEA: XBRL DOCUMENT

Other Balance Sheet Details

12 Months Ended

Dec. 31, 2021

Other Balance Sheet Details [Abstract]

Inventory consisted of the following:


	December 31,
(in millions)	2021		2020
Raw materials	$	11.2	$	16.6
Work in process	3.6		2.4
Finished goods	15.7		9.0
Total inventory	$	30.5	$	28.0

Property and equipment, net, consisted of the following:


	December 31,
(in millions)	2021		2020
Tenant improvements	$	34.9	$	29.5
Scientific equipment	51.6		39.2
Computer equipment	18.1		13.9
Furniture and fixtures	5.9		3.7
	110.5		86.3
Less accumulated depreciation	(51.9)		(41.7)
Total property and equipment, net	$	58.6	$	44.6

Accounts payable and accrued liabilities consisted of the following:


	December 31,
(in millions)	2021		2020
Accrued employee related costs	$	50.6	$	38.2
Revenue-related reserves for discounts and allowances	62.7		34.6
Accrued development costs	32.4		32.9
Current branded prescription drug fee	28.6		23.6
Accounts payable and other accrued liabilities	51.5		39.4
Total accounts payable and accrued liabilities	$	225.8	$	168.7

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.


	December 31,
(in millions)	2021		2020
Cash and cash equivalents	$	340.8	$	187.1
Restricted cash	3.2		3.2
Total cash, cash equivalents and restricted cash	$	344.0	$	190.3